NUS study identifies potential ‘master switch’ in aggressive breast cancer
Experimental drug Supinoxin was found to suppress tumour growth and target treatment-resistant cancer stem cells in preclinical studies, opening a possible path towards more personalised therapy. SINGAPORE: Researchers at the National University of Singapore have identified a potential way to disable a key molecular “master switch” that enables an